Jnana Therapeutics picks up $50m Series B

Jnana Therapeutics, a biotechnology company, has secured $50 million in Series B financing.

Jnana Therapeutics, a biotechnology company, has secured $50 million in Series B financing. RA Capital Management led the round.

Source: Press Release